Using a surveillance system to identify and treat newly acquired hepatitis C infection.
Nick Walsh, Megan Lim, Margaret Hellard
Journal of Gastroenterology and Hepatology | Published : 2008
BACKGROUND AND AIM: Hepatitis C treatment uptake in Australia is low. We describe the rate of acute hepatitis C treatment in the Australian state of Victoria by linking the centralized passive notifications system for hepatitis C with the Australian Trial in Acute Hepatitis C (ATAHC), a nationwide clinical trial aimed at providing people with newly acquired hepatitis C with 24 weeks' pegylated interferon monotherapy. METHODS: Mandatory notifications of clinical or laboratory evidence of hepatitis C were further investigated for evidence of newly acquired infection. Followed-up individuals were then screened for eligibility for the ATAHC study (which included documented hepatitis C antibody p..View full abstract